In this review, we discuss the clinical relevance of therapeutic strategies that target the IGF/IGF-1R axis in multiple malignant tumors and the applicability of IGF/IGF-1R axis strategies to improve stem cell-based therapies for human diseases. This evidence concerns the gene IGF1 and cancer.